🇺🇸 FDA
Patent

US 9616102

Analogs of ShK toxin and their uses in selective inhibition of Kv1.3 potassium channels

granted A61KA61K38/1767A61K47/542

Quick answer

US patent 9616102 (Analogs of ShK toxin and their uses in selective inhibition of Kv1.3 potassium channels) held by The Regents of the University of California expires Mon Apr 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Apr 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
32
CPC classes
A61K, A61K38/1767, A61K47/542, A61K47/6415, A61P